Translation services for the sherlock-lung genomic epidemiologic study of lung cancer in never smokers in support of the NIH, NCI, division of cancer epidemiology and genetics (dceg)
Ended Awarded Last action
- Contract number
- 75N91022F00001
- Awardee
-
Prescient Technologies, LLC UEI V6QDML49NW17
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $38,106
Award facts
- Opportunity
-
- 75N91022Q00186 Solicitation number
- Contract value 100% obligated
- $38,105.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541930 Translation and Interpretation Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Leesburg, VA, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $26,000 | |
| Original award | $12,106 |
About this award
This delivery order for translation services supports the Sherlock-Lung Genomic Epidemiologic Study of Lung Cancer in Never Smokers conducted by the Division of Cancer Epidemiology and Genetics within the National Cancer Institute, part of the National Institutes of Health and Department of Health and Human Services. Prescient Technologies, LLC, an 8(a) Program participant, received a firm fixed price award of $38,105.86 to provide translation services for the study through September 15, 2023. The potential value matches the award amount. Prescient Technologies will perform at locations in Leesburg, Virginia to support epidemiological research on lung cancer in nonsmokers through ensuring effective language access across the genomic study.
Quick answers
Who was awarded contract 75N91022F00001?
75N91022F00001 was awarded to Prescient Technologies, LLC by National Cancer Institute (National Institutes of Health) on September 16, 2022.
How much is contract 75N91022F00001 worth?
The government has obligated $38,106 on 75N91022F00001.
Is contract 75N91022F00001 an order under another contract?
Yes. 75N91022F00001 is a delivery order under 75N98022D00045, an indefinite delivery contract.
Was contract 75N91022F00001 competed?
The extent of competition for 75N91022F00001 was full and open competition after exclusion of sources.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award